[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"parotid-neoplasms\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:parotid-neoplasms":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,54],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":42,"lastUpdatePostDateStruct":43,"startDateStruct":46,"completionDateStruct":48,"leadSponsor":50,"locationsCount":53},"100640362","swedish-national-parotidectomy-study-snaps-drainless-versus-standard-surgery-100640362",false,"NCT07620184","Swedish National Parotidectomy Study (SNaPs): Drainless Versus Standard Surgery","A Prospective, Randomized, Multicenter Non-Inferiority Trial Evaluating the Safety of Parotidectomy Without Active Surgical Drainage (Svenska Nationella Parotisstudien)","SNaPs","Inclusion Criteria:\n\n* Patients scheduled to undergo partial or superficial parotidectomy without concurrent soft tissue surgery, in cases where a wound drain is traditionally used (extirpation of single adjacent lymph nodes is acceptable).\n* ASA physical status class 1-3.\n* Aged 18 years or older.\n* The patient understands the participant information and is able to make an informed choice.\n\nExclusion Criteria:\n\n* Previous parotid surgery on the same side\n* Tumour with parapharyngeal extension.\n* Ongoing or planned perioperative treatment with tranexamic acid.\n* Ongoing treatment with dual antiplatelet therapy (single agent therapy, such as Aspirin or Clopidogrel, is not an exclusion criterion).\n* Ongoing treatment with anticoagulants (NOAC, Warfarin) at the time of surgery. NOAC must be discontinued at least 24 hours before surgery.\n* Ongoing treatment with low molecular weight heparin in doses higher than: Fragmin 5000 IU\u002Fday, Clexane 40 mg\u002Fday, or Innohep 4500 IU\u002Fday.Ongoing treatment for malignancy.Known coagulation disorder.\n* Platelet count \\\u003C150 x 10⁹\n* PK-INR \\>1.2.\n* Hb \\\u003C120 g\u002FL.\n* APTT \\>42s.\n* Preoperative impaired facial nerve function on the affected side (Sunnybrook Facial Grading System score \\\u003C90).\n* Supplementary postoperative treatment such as radiotherapy or extended surgery.","ALL","18 Years",{"count":20,"type":21},600,"ESTIMATED","INTERVENTIONAL",[24],"NA","The purpose of this study The purpose of this study is to find out if it is safe to perform surgery on the parotid gland (the large salivary gland in front of the ear) without using a wound drain. A wound drain is a small plastic tube used to remove excess fluid from the surgical site after the operation. Currently, using a drain is the standard practice in Sweden, which often means patients must stay in hospital overnight. Researchers want to see if skipping the drain is just as safe and if it could allow more patients to return home on the same day as their surgery.\n\nWhat happens during the study\n\nParticipants in this study will be randomly assigned to one of two groups during their surgery:\n\nGroup 1: Will receive the standard treatment with a wound drain.\n\nGroup 2: Will have the surgery performed without a wound drain.\n\nApart from the use of a drain, all participants will receive the same surgical care. After the operation, researchers will monitor the healing process. Participants will be asked to fill out questionnaires about their health and any symptoms at one week and six months after their surgery.\n\nThe goal of the study The main goal is to compare the safety of the two methods. Researchers will look at whether there is any difference in the number of complications, such as fluid build-up (seroma), bleeding, or infections, between those who had a drain and those who did not. The study also aims to evaluate if avoiding a drain improves the patient's quality of life and if it is a more cost-effective approach for the healthcare system.",[27,28,29],"Parotid Neoplasms","Post-operative Complications","Seroma as Procedural Complication",[31,32,33,34,35,36,37,38,39,40],"Parotidectomy","Surgical drainage","Wound drains","Postoperative complications","Seroma","Hematoma","Randomised controlled trial","Non-inferiority","Salivary gland surgery","Quality of life","RECRUITING","2026-06-02",{"date":44,"type":45},"2026-06-04","ACTUAL",{"date":47,"type":45},"2026-05-06",{"date":49,"type":21},"2032-12",{"name":51,"class":52},"Uppsala University Hospital","OTHER",3,{"id":55,"slug":56,"hasResults":11,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":4,"eligibilityCriteria":60,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":61,"targetDuration":4,"studyType":22,"phases":63,"briefSummary":64,"conditions":65,"keywords":4,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":75},"100462011","application-of-3d-mr-neurogram-for-intraparotid-facial-nerves-evaluation-100462011","NCT05296109","Application of 3D MR Neurogram for Intraparotid Facial Nerves Evaluation","Application of 3D Magnetic Resonance Neurogram Sequences for Evaluation of Intraparotid Facial Nerves in Patients With Parotid Neoplasm","Inclusion Criteria:\n\n* Consecutive patients with parotid tumour diagnosed on other imaging modalities (such as ultrasonography or computed tomography), with or without cytological diagnosis from fine needle aspiration, will be recruited from the ear, nose and throat specialty clinic.\n\nExclusion Criteria:\n\n* Patients who are contraindicated to magnetic resonance imaging (such as due to underlying MRI incompatible metallic implants)\n* Patient who are contraindicated to MRI contrast agents (such as advanced renal failure or previous severe allergic reaction)\n* Patients who cannot cooperate for MRI scanning.\n* Patients show are unable to provide informed consent.",{"count":62,"type":21},50,[24],"Parotid neoplasm consists of a wide range of benign and malignant lesions, and parotidectomy has been the mainstay for management of these neoplasms. Within the parotid gland there are branches of the intra-parotid facial nerves, which are tiny in calibre and are prone to injury to injury during operation. It has been reported in recent retrospective view that the incidence of temporary and permanent facial nerve injury were 9.2% and 5.2% respectively, the risk of which increased with old age, malignant tumour and revision surgery. Traditional the incidental of facial nerve injury is reduced by intra-operative facial nerve monitoring and surgical magnification, while imaging has limited role in aiding this purpose. However with advancement in MRI technique high resolution three-dimensional sequences (i.e. neurogram sequences) are available for better visualization of branches of facial nerves. The investigators would therefore aim to demonstrate additional efficacy of these techniques and also to compare with conventional 3D post-contrast anatomical imaging studies in the localization and visualization of the facial nerve branches in patients with tumour. With better pre-operative imaging, the investigators hope to reduce the chance of facial nerve injury in these patients.",[27],"2026-03-30",{"date":68,"type":45},"2026-04-03",{"date":70,"type":45},"2022-02-01",{"date":72,"type":21},"2027-06-30",{"name":74,"class":52},"Chinese University of Hong Kong",1]